Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis.
Nonalcoholic fatty liver disease (NAFLD) includes simple steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma. The gut-derived endotoxin plays an essential role in the pathophysiological development and progression of NAFLD. By using rat models of choline...
Main Authors: | Hitoshi Endo, Maki Niioka, Noriko Kobayashi, Mamoru Tanaka, Tetsu Watanabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3656030?pdf=render |
Similar Items
-
Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
by: Tian-Yi Ren, et al.
Published: (2021-01-01) -
Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease
by: Meng-Wei Xiao, et al.
Published: (2019-01-01) -
Induction of peroxisomes by butyrate-producing probiotics.
by: Huachun Weng, et al.
Published: (2015-01-01) -
Probiotics modify tight-junction proteins in an animal model of nonalcoholic fatty liver disease
by: David Briskey, et al.
Published: (2016-07-01) -
Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis
by: Yao Tang, et al.
Published: (2019-09-01)